Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Innovation Pharmaceuticals Inc (IPIX) Message Board

Obviously if the stock price makes it's way to upl

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 72447
(Total Views: 297)
Posted On: 08/25/2018 12:33:10 PM
Avatar
Posted By: Squar
Re: Dynabolic #48045
Obviously if the stock price makes it's way to uplisting with new all time highs ($5+), then a $2B buyout is probably no longer in the cards. We would likely have a fresh Aspire contract if needed and a market to sell into.

Does a $10-20M upfront + trial costs on B-OM get us to an uplist? Granted, that combined with a 40%PASI75 on Prurisol would probably do so as a deal/sale of P would be assured at that point. What if P disappoints? Then we have to wait another couple years to get the result of B-OM phase 3 while trickling sales to Aspire (would they even fund us going into this plan?) to get another Kevetrin trial going?

I don't think anyone expected it would be 2019 before a Prurisol phase 3 (or 505b NDA application) would begin. It's a question of timelines and how much time one wants to spend in the risk zone.

I think some are overestimating Leo's hand at the bargaining table. The terms of the Aspire sales have deteriorated considerably this year. Advancing a drug on our own would be very painful to current shareholders and there is no gaurentee of success. A $2 billion buyout would be a huge and gaurenteed success for every shareholder.

I'm optimistic on Prurisol but the reason I'm holding here is because I believe that in the worst of situations we could sell the company for $100M+ (above the current market cap) just for B-ABSSSI. This is not where I thought we would be as we barrel through the second half of 2018.


(1)
(4)




Innovation Pharmaceuticals Inc (IPIX) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us